Continuous Dissolution Testing
Continuous Dissolution Testing is a dissolution testing methodology that continuously monitors drug release from a dosage form in real-time throughout the entire dissolution process, distinguished from discrete or periodic methods by its uninterrupted data acquisition and dynamic assessment of solubility behavior.
44
Publications
1.5K
Citations
155
Authors
50
Institutions
Publications per year
2017–2026
3
44
1–5 of 44
155
3
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 155
50
Center for Drug Evaluation and Research
Silver Spring, United States
3 h-index
9 publications
606 citations
Pfizer (United States)
New York, United States
2 h-index
6 publications
402 citations
University of Kansas
Lawrence, United States
2 h-index
5 publications
122 citations

University of Eastern Finland
Joensuu, Finland
2 h-index
7 publications
125 citations
New Jersey Institute of Technology
Newark, United States
2 h-index
4 publications
76 citations
Institute of Occupational Medicine
Edinburgh, United Kingdom
2 h-index
7 publications
273 citations
Merck & Co., Inc., Rahway, NJ, USA (United States)
Rahway, United States
2 h-index
6 publications
105 citations

Northeastern University
Shenyang, China
2 h-index
9 publications
267 citations
1–8 of 50
7 publications · 161 citations
7
h-index
6 publications · 134 citations
6
h-index
6 publications · 163 citations
6
h-index
4 publications · 185 citations
4
h-index
3 publications · 176 citations
3
h-index
1–5